Syntaxin 1: A Novel Robust Immunophenotypic Marker of Neuroendocrine Tumors

scientific article published on 12 February 2020

Syntaxin 1: A Novel Robust Immunophenotypic Marker of Neuroendocrine Tumors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/IJMS21041213
P932PMC publication ID7072745
P698PubMed publication ID32059362

P2093author name stringZoltán Fekete
László Krenács
Ágnes Báthori
Bence Kővári
Sándor Turkevi-Nagy
P2860cites workDifferent patterns of chromogranin A and Leu-7 (CD57) expression in gastrointestinal carcinoids: immunohistochemical and confocal laser scanning microscopy studyQ28190126
Chromogranin A: its clinical value as marker of neuroendocrine tumoursQ28278648
Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfallQ30843609
Cloning and sequence analysis of cDNA for a neuronal cell membrane antigen, HPC-1Q31170841
Synaptophysin: a marker protein for neuroendocrine cells and neoplasmsQ35606412
Practical markers used in the diagnosis of neuroendocrine tumorsQ35636285
Identification of synaptic proteins and their isoform mRNAs in compartments of pancreatic endocrine cellsQ35986944
Endocrine tumours of the gastrointestinal tract-selected topicsQ36699524
Molecular Mechanisms for the Coupling of Endocytosis to Exocytosis in Neurons.Q37694518
The Multifaceted Role of SNARE Proteins in Membrane Fusion.Q39121037
Argyrophil cell hyperplasia of fundic mucosa in patients with chronic atrophic gastritisQ45195729
Medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognized by monoclonal antibody HISL-19Q67975743
Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoidsQ69014655
Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tractQ71842426
CD56: a useful marker for diagnosing Merkel cell carcinomaQ73342835
Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumorsQ77321927
Chromogranin A in the human gastrointestinal tract: an immunocytochemical study with region-specific antibodiesQ78477714
Presence of syntaxin 1A in secretory granules of chromaffin cells and interaction with chromogranins A and BQ81202039
Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine NeoplasmsQ88008594
Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostateQ89049283
Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasmsQ90702187
INSM1 Is More Sensitive and Interpretable than Conventional Immunohistochemical Stains Used to Diagnose Merkel Cell CarcinomaQ90773786
Insulinoma-associated protein 1 expression in primary and metastatic neuroendocrine neoplasms of the gastrointestinal and pancreaticobiliary tractsQ91940588
Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesiclesQ48475060
INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors.Q50042532
A comprehensive immunophenotypic marker analysis of hairy cell leukemia in paraffin-embedded bone marrow trephine biopsies--a tissue microarray study.Q50469577
INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity.Q50884052
Characterization of HPC-1 antigen, an isoform of syntaxin-1, with the isoform-specific monoclonal antibody, 14D8.Q52196470
Targeting of voltage-gated K+ and Ca2+ channels and soluble N-ethylmaleimide-sensitive factor attachment protein receptor proteins to cholesterol-rich lipid rafts in pancreatic alpha-cells: effects on glucagon stimulus-secretion coupling.Q52577065
Immunohistochemistry in Diagnostic Parathyroid Pathology.Q52601593
Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the small intestine and ampulla.Q52905786
Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the colon and rectum.Q52905790
INSM1: A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms.Q52915848
A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposalQ56341375
Chromogranin A in gastric neuroendocrine tumours: an immunohistochemical and biochemical study with region-specific antibodiesQ56998485
Mechanism of neurotransmitter release coming into focusQ57173506
Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56Q57789827
Synaptophysin: A novel marker for neurons, certain neuroendocrine cells, and their neoplasmsQ58439078
A Web-based Tool forin SilicoBiomarker Discovery Based on Tissue-specific Protein Profiles in Normal and Cancer TissuesQ61445583
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue4
P577publication date2020-02-12
P1433published inInternational Journal of Molecular SciencesQ3153277
P1476titleSyntaxin 1: A Novel Robust Immunophenotypic Marker of Neuroendocrine Tumors
P478volume21